Cyprotex
Simon Wood is an accomplished professional with extensive experience in the field of bioanalysis and analytical sciences. Currently serving as the Head of Analytical Sciences at Cyprotex since August 2018, Simon has previously held key leadership positions, including Head of Development Bioanalysis at York Bioanalytical Solutions from April 2016 to July 2018, and Associate Director of Method Development at Celerion from April 2011 to March 2016. With a strong background in method development and bioanalytical strategies, Simon Wood has made significant contributions to the advancements in scientific research and analysis.
This person is not in any offices
Cyprotex
Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and USA, was acquired by Evotec (www.evotec.com) in 2016. The Evotec Group offer expert support from early discovery through to clinical development. * High-throughput ADME screening * Customised ADME assays * In silico ADME predictive modeling * In vitro toxicology